- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Cinthya Pena Orbea Discusses Socioeconomic Impacts on Sleep-Disordered Breathing
Many socioeconomic factors, such as neighborhood factors, access to care, and education can influence sleep, explained Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic.
At SLEEP 2022, Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic, discussed how socioeconomic factors can influence sleep-disordered breathing.
What did your study find about the relationship between socioeconomic status and sleep-disordered breathing?
There are many socioeconomic factors that can influence sleep, and that could be neighborhood factors, access to care, education. In our study, what we wanted to study is the association between ADI—which stands for area deprivation index, which is a biomarker of neighborhood socioeconomic disadvantage—the association of these and sleep disorder breathing measures. What we found was that sleep-related hypoxia was higher among those people living in higher areas of deprivation.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
